Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HVMN (Health Via Modern Nutrition) is a biotechnology and consumer health company that specializes in metabolic technologies and exogenous ketones. The company is best known for developing Ketone-IQ, a drinkable ketone ester designed to elevate blood ketone levels for improved athletic performance, cognitive focus, and metabolic health. Originally founded as Nootrobox, the company pivoted from general nootropics to a focus on ketogenic science, securing a $6 million contract with the U.S. Department of Defense to study the effects of ketones on elite operator performance. HVMN operates at the intersection of nutrition and pharmacology, providing products backed by clinical research to both elite athletes and the general public.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ketone.com.